BCM

BML Capital Management Portfolio holdings

AUM $124M

AUM

$124M

AUM Growth

-$37.4M (-23%)

Cap. Flow

+$24.1M

Cap. Flow % of AUM

19.5%

Top 10 Holdings %Top 10 Hldgs %

86.46%

Holding

31

New

6

Increased

8

Reduced

3

Closed

4

Top Buys

1	Third Harmonic Bio THRD	$13.3M
2	LAVA Therapeutics LVTX	$2.49M
3	Adverum Biotechnologies ADVM	$2.07M
4	Kezar Life Sciences KZR	$1.75M
5	Elevation Oncology ELEV	$1.53M

Top Sells

1	WHWK Whitehawk Therapeutics, Inc. Common Stock WHWK	$373K
2	Lisata Therapeutics LSTA	$159K

Sector Composition

1	Healthcare	98.84%
2	Technology	1.16%

#	Name	Market Value	Portfolio Weight	Shares or Principal	Shares Change %	Capital Flow
26	26 HilleVax HLVX $93.2M	$30.1K	0.02%	20,760	–	–
27	27 iShares 0-3 Month Treasury Bond ETF SGOV $46.8B	$0	0%	0 -260,000	Closed	–
28	LENZ 28 LENZ Therapeutics LENZ $793M	$0	0%	0 -9,271	Closed	–
29	PVLA 29 Palvella Therapeutics, Inc. Common Stock PVLA $262M	$0	0%	0 -42,130	Closed	–
30	KLRS 30 Kalaris Therapeutics, Inc. Common Stock KLRS $52.2M	$0	0%	0 -184,246	Closed	–
31	ACHL 31 DELISTED Achilles Therapeutics plc American Depositary Shares ACHL	$0	0%	3,804,921 -295,081	-7%	–